Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 101 B, Issue 1, 2013, Pages 91-98

  Huntimer, Lucas ^a   Wilson Welder, Jennifer H ^a   Ross, Kathleen ^b   Carrillo Conde, Brenda ^b   Pruisner, Lynn ^b   Wang, Chong ^a,c   Narasimhan, Balaji ^b   Wannemuehler, Michael J ^a   Ramer Tait, Amanda E ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b Iowa State University of Science and Technology   (United States)

^c Department of Statistics Center for Statistics and Applications in Forensic Evidence Iowa State University 2438 Osborn Dr Ames   (United States)

Author keywords

adjuvant; avidity; microparticle; ovalbumin; polyanhydride

Indexed keywords

ADJUVANT; AVIDITY; MICRO PARTICLES; OVALBUMINS; POLYANHYDRIDES;

ANTIGENS; IMMUNOLOGY; MAMMALS;

ANTIBODIES;

ANTIBODY; OVALBUMIN; POLYANHYDRIDE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IN VITRO STUDY; MOUSE; NONHUMAN;

ANIMALS; ANTIBODY FORMATION; ANTIGENS; FEMALE; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C3H; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; POLYANHYDRIDES;

EID: 84871389613     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.32820     Document Type: Article

References (42)

1. Tritto E, Mosca F, De Gregorio E,. Mechanism of action of licensed vaccine adjuvants. Vaccine 2009; 27: 3331-3334.
2. Collin N, de Radiguès X,. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 2009; 27: 5184-5186.
3. Sallusto F, Lanzavecchia A, Araki K, Ahmed R,. From vaccines to memory and back. Immunity; 33: 451-463.
4. Bemark M, Bergqvist P, Stensson A, Holmberg A, Mattsson J, Lycke NY,. A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development. J Immunol 2011; 186: 1399-1410.
5. Lam XM, Duenas ET, Daugherty AL, Levin N, Cleland JL,. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. J Control Release 2000; 67: 281-292. (Pubitemid 30303842)
6. Semete B, Booysen L, Lemmer Y, Kalombo L, Katata L, Verschoor J, Swai H,. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine 2010; 6: 662-671.
7. Chong CSW, Cao M, Wong WW, Fischer KP, Addison WR, Kwon GS, Tyrrell DL, Samuel J,. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. J Control Release 2005; 102: 85-99. (Pubitemid 40093778)
8. Jiang W, Gupta RK, Deshpande MC, Schwendeman SP,. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 2005; 57: 391-410. (Pubitemid 39550967)
9. Determan AS, Wilson JH, Kipper MJ, Wannemuehler MJ, Narasimhan B,. Protein stability in the presence of polymer degradation products: Consequences for controlled release formulations. Biomaterials 2006; 27: 3312-3320. (Pubitemid 43344342)
10. Lu W, Park TG,. In vitro release profiles of eristostatin from biodegradable polymeric microspheres: Protein aggregation problem. Biotechnol Prog 1995; 11: 224-227.
11. Schwendeman S, Costantino H, Gupta R, Langer R,. Peptide, protein, and vaccine delivery from implantable polymeric systems. In:, Park K, editor. Controlled Drug Delivery: Challenges and Strategies. Washington, DC: ACS Books; 1997. p 229-267.
12. Shenderova A, Burke T, Schwendeman SP,. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins. Pharm Res 1999; 16: 241-248.
13. Kumar N, Langer RS, Domb AJ,. Polyanhydrides: An overview. Adv Drug Deliv Rev 2002; 54: 889-910.
14. Torres MP, Determan AS, Mallapragada SK, Narasimhan B,. Polyanhydrides. In:, Lee S, editor. Encyclopedia of Chemical Processing. New York: Marcell Dekker; 2005.
15. Determan AS, Trewyn BG, Lin VSY, Nilsen-Hamilton M, Narasimhan B,. Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres. J Control Release 2004; 100: 97-109. (Pubitemid 39445989)
16. Torres MP, Determan AS, Anderson GL, Mallapragada SK, Narasimhan B,. Amphiphilic polyanhydrides for protein stabilization and release. Biomaterials 2007; 28: 108-116. (Pubitemid 44427910)
17. Lopac SK, Torres MP, Wilson-Welder JH, Wannemuehler MJ, Narasimhan B,. Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres. J Biomed Mater Res B 2009; 91B: 938-947.
18. Kipper MJ, Wilson JH, Wannemuehler MJ, Narasimhan B,. Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism. J Biomed Mater Res A 2006; 76A: 798-810. (Pubitemid 47233489)
19. Torres MP, Wilson-Welder JH, Lopac SK, Phanse Y, Carrillo-Conde B, Ramer-Tait AE, Bellaire BH, Wannemuehler MJ, Narasimhan B,. Polyanhydride microparticles enhance dendritic cell antigen presentation and activation. Acta Biomater 2011; 7: 2857-2864.
20. Petersen LK, Xue L, Wannemuehler MJ, Rajan K, Narasimhan B,. The simultaneous effect of polymer chemistry and device geometry on the in vitro activation of murine dendritic cells. Biomaterials 2009; 30: 5131-5142.
21. Petersen LK, Ramer-Tait AE, Broderick SR, Kong C-S, Ulery BD, Rajan K, Wannemuehler MJ, Narasimhan B,. Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants. Biomaterials 2011; 32: 6815-6822.
22. Pollock KGJ, Conacher M, Wei X-Q, Alexander J, Brewer JM,. Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12. Immunology 2003; 108: 137-143. (Pubitemid 36232862)
23. Conix A,. Poly[1,3-bis(p-carboxyphenoxy)-propane anhydride]. Macromol Synth 1966; 2: 95-98.
24. Kipper MJ, Shen E, Determan A, Narasimhan B,. Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. Biomaterials 2002; 23: 4405-4412.
25. Shen E, Pizsczek R, Dziadul B, Narasimhan B,. Microphase separation in bioerodible copolymers for drug delivery. Biomaterials 2001; 22: 201-210.
26. Carrasquillo KG, Stanley AM, Aponte-Carro JC, De Jesus P, Costantino HR, Bosques CJ, Griebenow K,. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J Control Release 2001; 76: 199-208. (Pubitemid 32913430)
27. Gupta RK, Chang AC, Siber GR,. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. Dev Biol Stand 1998; 92: 63-78.
28. Gupta RK, Singh M, O'Hagan DT,. Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines. Adv Drug Deliv Rev 1998; 32: 225-246. (Pubitemid 28267411)
29. Lutsiak ME, Kwon GS, Samuel J,. Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. J Pharm Pharmacol 2006; 58: 739-747. (Pubitemid 43836161)
30. Conway MA, Madrigal-Estebas L, McClean S, Brayden DJ, Mills KH,. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: Effect of formulation and route of immunization on induction of Th1 and Th2 cells. Vaccine 2001; 19: 1940-1950. (Pubitemid 32178342)
31. McNeela EA, Mills KH,. Manipulating the immune system: Humoral versus cell-mediated immunity. Adv Drug Deliv Rev 2001; 51: 43-54. (Pubitemid 32763071)
32. Ulery B, Phanse Y, Sinha A, Wannemuehler M, Narasimhan B, Bellaire B,. Polymer chemistry influences monocytic uptake of polyanhydride nanospheres. Pharm Res 2009; 26: 683-690.
33. Flach TL, Ng G, Hari A, Desrosiers MD, Zhang P, Ward SM, Seamone ME, Vilaysane A, Mucsi AD, Fong Y, Prenner E, Ling CC, Tschopp J, Muruve DA, Amrein MW, Shi Y,. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat Med 2011; 17: 479-487.
34. Kool M, Soullié T, van Nimwegen M, Willart MAM, Muskens F, Jung S, Hoogsteden HC, Hammad H, Lambrecht BN,. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2008; 205: 869-882. (Pubitemid 351549884)
35. Kool M, Pétrilli V, De Smedt T, Rolaz A, Hammad H, van Nimwegen M, ergen IM, Castillo R, Lambrecht BN, Tschopp J,. Cutting edge: Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 2008; 181: 3755-3759.
36. Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM,. Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded β-glucan particles. mBio 2010; 1: e00164-10.
37. Brewer JM, Conacher M, Satoskar A, Bluethmann H, Alexander J,. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Eur J Immunol 1996; 26: 2062-2066. (Pubitemid 26297502)
38. Sun H-X, Pan H-J,. Immunological adjuvant effect of Glycyrrhiza uralensis saponins on the immune responses to ovalbumin in mice. Vaccine 2006; 24: 1914-1920. (Pubitemid 43238274)
39. Ochsenbein AF, Pinschewer DD, Sierro S, Horvath E, Hengartner H, Zinkernagel RM,. Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc Natl Acad Sci U S A 2000; 97: 13263-13268.
40. Elgueta R, De Vries VC, Noelle RJ,. The immortality of humoral immunity. Immunol Rev 2010; 236: 139-150.
41. Bachmann MF, Jennings GT,. Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 2010; 10: 787-796.
42. Ulery BD, Petersen LK, Phanse Y, Kong CS, Broderick SR, Kumar D, Ramer-Tait AE, Carrillo-Conde B, Rajan K, Wannemuehler MJ, Belliare B, Metzger DW, Narasimhan B,. Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants. Nat Sci Rep 2011; 1: 198. doi:10.1038/srep00198.